203 related articles for article (PubMed ID: 23584150)
1. A case of drug reaction with eosinophilia and systemic symptoms induced by ethambutol with early features resembling Stevens-Johnson syndrome.
Kim JY; Sohn KH; Song WJ; Kang HR
Acta Derm Venereol; 2013 Nov; 93(6):753-4. PubMed ID: 23584150
[No Abstract] [Full Text] [Related]
2. Drug-induced hypersensitivity syndrome by ethambutol: A case report.
Yoshioka Y; Hanafusa T; Namiki T; Nojima K; Amano M; Tokoro S; Igawa K; Yokozeki H
J Dermatol; 2016 Aug; 43(8):971-2. PubMed ID: 26891664
[No Abstract] [Full Text] [Related]
3. DRESS Syndrome and Chronic Renal Failure Induced by Ethambutol.
Jamel EG; Ahmed S
Am J Med Sci; 2019 Nov; 358(5):e19. PubMed ID: 31326092
[No Abstract] [Full Text] [Related]
4. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome due to ethambutol.
Gest N; Ingen-Housz-Oro S; Gener G; Bellanger M; Henn A; Gallien S; Flateau C
Med Mal Infect; 2018 Jun; 48(4):302-305. PubMed ID: 29602678
[No Abstract] [Full Text] [Related]
5. [CME. Severe cutaneous drug reaction].
Deuel J; Schaer D; Schmid-Grendelmeier P; Vallelian F
Praxis (Bern 1994); 2014 Oct; 103(21):1231-43. PubMed ID: 25305114
[No Abstract] [Full Text] [Related]
6. Drug reaction with eosinophilia and systemic symptoms with features resembling Stevens-Johnson syndrome/toxic epidermal necrolysis related to apalutamide.
Hsu YO; Hsieh TS; Huang PW; Chu CY
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):e246-e248. PubMed ID: 36223304
[No Abstract] [Full Text] [Related]
7. Leukapheresis in the management of drug rash with eosinophilia and systemic symptoms syndrome.
Martínez de Lagrán I; Marcos P; Batlle M; Alonso E; Plana A; Tomasa T
Med Intensiva; 2017 Apr; 41(3):191-193. PubMed ID: 27017438
[No Abstract] [Full Text] [Related]
8. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.
Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC
Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005
[TBL] [Abstract][Full Text] [Related]
9. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.
Darlenski R; Kazandjieva J; Tsankov N
Clin Dermatol; 2015; 33(5):538-41. PubMed ID: 26321400
[TBL] [Abstract][Full Text] [Related]
10. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
Hassoun-Kheir N; Bergman R; Weltfriend S
Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
[TBL] [Abstract][Full Text] [Related]
11. [DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS].
Bensaïd B; Valeyrie-Allanore L; Lebrun-Vignes B; Nicolas JF
Rev Prat; 2015 Sep; 65(7):981-5. PubMed ID: 26619740
[TBL] [Abstract][Full Text] [Related]
12. Allopurinol-induced drug rash with eosinophilia and systemic symptoms mimicking acute generalized exanthematous pustulosis.
Huang YC; Shih PY; Chin SY; Chiang YY
J Dermatol; 2012 Dec; 39(12):1077-8. PubMed ID: 22901319
[No Abstract] [Full Text] [Related]
13. [Concomitant Drug Reaction with Eosinophilia and Systemic Symptom Syndrome from Ethambutol and Autoimmune Hepatitis from Isoniazid].
Choi JH; Heo NY; Park SH; Park CS; Jo KM; Kim WG; Nam KH
Korean J Gastroenterol; 2016 May; 67(5):267-271. PubMed ID: 27206439
[TBL] [Abstract][Full Text] [Related]
14. Drug reaction with eosinophilia and systemic symptoms syndrome associated with antituberculosis medications.
Cheng J; Rawal S; Roberts A; Guttman OR
Pediatr Infect Dis J; 2013 Dec; 32(12):1388-90. PubMed ID: 24569311
[TBL] [Abstract][Full Text] [Related]
15. Positive Allergy Study (Intradermal, Patch, and Lymphocyte Transformation Tests) in a Case of Isoniazid-Induced DRESS.
Arruti N; Villarreal O; Bernedo N; Audicana MT; Velasco M; Uriel O; Martinez A; Bellón T
J Investig Allergol Clin Immunol; 2016; 26(2):119-20. PubMed ID: 27164631
[No Abstract] [Full Text] [Related]
16. Differential expression profile of Th1/Th2-associated chemokines characterizes Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) as distinct entities.
Miyagawa F; Hasegawa A; Imoto K; Ogawa K; Kobayashi N; Ito K; Fujita H; Aihara M; Watanabe H; Sueki H; Tohyama M; Asada H
Eur J Dermatol; 2015; 25(1):87-9. PubMed ID: 25547780
[No Abstract] [Full Text] [Related]
17. Treatments for Severe Cutaneous Adverse Reactions.
Cho YT; Chu CY
J Immunol Res; 2017; 2017():1503709. PubMed ID: 29445753
[TBL] [Abstract][Full Text] [Related]
18. Early high-dose intravenous corticosteroids rapidly arrest Stevens Johnson syndrome and drug reaction with eosinophilia and systemic symptoms recurrence on drug re-exposure.
Lehloenya RJ; Isaacs T; Nyika T; Dhana A; Knight L; Veenstra S; Peter J
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):582-584.e1. PubMed ID: 32835874
[No Abstract] [Full Text] [Related]
19. Febuxostat (Adenuric). Toxic epidermal necrolysis and severe hypersensitivity reactions added to the EU SPC.
Prescrire Int; 2015 Jun; 24(161):153. PubMed ID: 26436167
[TBL] [Abstract][Full Text] [Related]
20. Drug Rash with eosinophilia and systemic symptoms versus Stevens-Johnson Syndrome--a case that indicates a stumbling block in the current classification.
Wolf R; Davidovici B; Matz H; Mahlab K; Orion E; Sthoeger ZM
Int Arch Allergy Immunol; 2006; 141(3):308-10. PubMed ID: 16940741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
